|
1
|
Podolsky DK: Inflammatory bowel disease. N
Engl J Med. 347:417–429. 2002. View Article : Google Scholar
|
|
2
|
Chamaillard M, Philpott D, Girardin SE, et
al: Gene-environment interaction modulated by allelic heterogeneity
in inflammatory diseases. Proc Natl Acad Sci USA. 100:3455–3460.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakamoto N, Kono S, Wakai K, et al;
Epidemiology Group of the Research Committee on Inflammatory Bowel
Disease in Japan. Dietary risk factors for inflammatory bowel
disease: a multicenter case-control study in Japan. Inflamm Bowel
Dis. 11:154–163. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Head KA and Jurenka JS: Inflammatory bowel
disease part 1. Ulcerative colitis - pathophysiology and
conventional and alternative treatment options. Altern Med Rev.
8:247–283. 2003.PubMed/NCBI
|
|
5
|
Lakatos PL, Fischer S, Lakatos L, Gal I
and Papp J: Current concept on the pathogenesis of inflammatory
bowel disease-crosstalk between genetic and microbial factors:
pathogenic bacteria and altered bacterial sensing or changes in
mucosal integrity take ‘toll’? World J Gastroenterol. 12:1829–1841.
2006.
|
|
6
|
Gersemann M, Wehkamp J and Stange EF:
Innate immune dysfunction in inflammatory bowel disease. J Intern
Med. 271:421–428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
UK IBD Genetics Consortium. Barrett JC,
Lee JC, Lees CW, et al: Genomewide association study of ulcerative
colitis identifies three new susceptibility loci, including the
HNF4A region. Nat Genet. 41:1330–1334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Silverberg MS, Cho JH, Rioux JD, et al:
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by
genome-wide association study. Nat Genet. 41:216–220. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McGovern DP, Gardet A, Törkvist L, et al:
Genome-wide association identifies multiple ulcerative colitis
susceptibility loci. Nat Genet. 42:332–337. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Franke A, Balschun T, Sina C, et al:
Genome-wide association study for ulcerative colitis identifies
risk loci at 7q22 and 22q13 (IL17REL). Nat Genet. 42:292–294. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fukata M and Abreu MT: TLR4 signaling in
the intestine in health and disease. Biochem Soc Trans.
35:1473–1478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arancibia SA, Béltran CJ, Aguirre IM, et
al: Toll-like receptors are key participants in innate immune
responses. Biol Res. 40:97–112. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Z, Nakajima T, Inoue Y, et al: A
single nucleotide polymorphism in the 3′-untranslated region of
MyD88 gene is associated with Buerger disease but not with Takayasu
arteritis in Japanese. J Hum Genet. 56:545–547. 2011.
|
|
14
|
Mishra PJ and Bertino JR: MicroRNA
polymorphisms: the future of pharmacogenomics, molecular
epidemiology and individualized medicine. Pharmacogenomics.
10:399–416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siddique I and Khan I: Mechanism of
regulation of Na-H Exchanger in inflammatory bowel disease: role of
TLR-4 signaling mechanism. Dig Dis Sci. 56:1656–1662. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Podolsky DK: Inflammatory bowel disease
(2). N Engl J Med. 325:1008–1016. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arisawa T, Tahara T, Shibata T, et al: A
polymorphism of microRNA 27a genome region is associated with the
development of gastric mucosal atrophy in Japanese male subjects.
Dig Dis Sci. 52:1691–1697. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arisawa T, Tahara T, Shiroeda H, et al:
NFKB1 polymorphism is associated with age-related gene methylation
in Helicobacter pylori-infected subjects. Int J Mol Med.
30:255–262. 2012.PubMed/NCBI
|
|
19
|
Ruemmele FM, Beaulieu JF, Dionne S, et al:
Lipopolysaccharide modulation of normal enterocyte turnover by
toll-like receptors is mediated by endogenously produced tumour
necrosis factor alpha. Gut. 51:842–848. 2002. View Article : Google Scholar
|
|
20
|
Boone DL and Ma A: Connecting the dots
from Toll-like receptors to innate immune cells and inflammatory
bowel disease. J Clin Invest. 111:1284–1286. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pierik M, Joossens S, Van Steen K, et al:
Toll-like receptor-1, -2, and -6 polymorphisms influence disease
extension in inflammatory bowel diseases. Inflamm Bowel Dis.
12:1–8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lubbad A, Oriowo MA and Khan I: Curcumin
attenuates inflammation through inhibition of TLR-4 receptor in
experimental colitis. Mol Cell Biochem. 322:127–135. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sepúlveda SE, Beltrán CJ, Peralta A, et
al: Inflammatory bowel diseases: an immunological approach. Rev Med
Chil. 136:367–375. 2008.(In Spanish).
|
|
24
|
Cantó E, Ricart E, Monfort D, et al: TNF
alpha production to TLR2 ligands in active IBD patients. Clin
Immunol. 119:156–165. 2006.PubMed/NCBI
|
|
25
|
Tomita T, Kanai T, Fujii T, et al:
MyD88-dependent pathway in T cells directly modulates the expansion
of colitogenic CD4+ T cells in chronic colitis. J
Immunol. 180:5291–5299. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aoyagi Y, Nagata S, Kudo T, et al:
Peroxisome proliferator- activated receptor γ 2 mutation may cause
a subset of ulcerative colitis. Pediatr Int. 52:729–734. 2010.
|
|
27
|
Hugot JP and Thomas G: Genome-wide
scanning in inflammatory bowel diseases. Dig Dis. 16:364–369. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Scott GK, Goga A, Bhaumik D, Berger CE,
Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3
by enforced expression of micro-RNA miR-125a or miR-125b. J Biol
Chem. 282:1479–1486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Potter C, Cordell HJ, Barton A, et al;
Biologics in Rheumatoid Arthritis Genetics and Genomics Study
Syndicate (BRAGGSS). Association between anti-tumour necrosis
factor treatment response and genetic variants within the TLR and
NF{kappa}B signalling pathways. Ann Rheum Dis. 69:1315–1320.
2010.PubMed/NCBI
|
|
30
|
Cho JH and Brant SR: Genetics and genetic
markers in inflammatory bowel disease. Curr Opin Gastroenterol.
14:283–288. 1998. View Article : Google Scholar
|
|
31
|
Fisher SA, Hampe J, Macpherson AJ, et al:
Sex stratification of an inflammatory bowel disease genome search
shows male-specific linkage to the HLA region of chromosome 6. Eur
J Hum Genet. 10:259–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
